Has been described as a specific inhibitor of collagen-induced platelet aggregation (PubMed:8106481). However, as it does not affect platelet shape change or adhesion, it is plausible that it exerts its antiplatelet activity by a mechanism similar to that of triplatin, moubatin and dipetalodipin as scavenging eicosanoids involved in inflammation such as thromboxan A2 (TXA2) (PubMed:20889972) (By similarity). Expressed in salivary glands. Belongs to the calycin superfamily. Triabin family.